Characterization and Modulation of Functional Connectivity and Fear Extinction Abnormalities in Obsessive-Compulsive Disorder

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposure therapy is among the first-line of treatments for obsessive-compulsive disorder (OCD) . Extinction learning is thought to be a core mechanism of therapeutic exposure. Fear and safety signal learning are traditionally associated with activity and connectivity within the canonical corticolimbic fear circuit, which includes the amygdala, medial prefrontal cortex (mPFC), and hippocampus. Transcranial direct current stimulation (tDCS) is a neuromodulation technology that can augment brain plasticity, learning, and memory. The proposed study will test if obsessive-compulsive disorder (OCD) is associated with inhibitory safety learning deficits and if transcranial direct current stimulation (tDCS) normalizes functional connectivity and safety signal processing to recover extinction deficits in obsessive-compulsive disorder (OCD).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:

• All Participant Inclusion Criteria would include:

‣ 18 years of age or older

⁃ speak English fluently, and

⁃ able to provide written and verbal informed consent.

• Obsessive-compulsive disorder (OCD) Inclusion Criteria would include:

‣ meet criteria for OCD as determined by structured clinical interview

⁃ exhibit significant current symptoms of OCD

⁃ report duration of OCD symptoms of at least 1-year

⁃ OCD symptoms are primary or co-primary relative to other psychiatric diagnoses

⁃ stable psychiatric treatment (≥8-weeks) or no active treatment.

Locations
United States
Connecticut
Temple Medical Center
RECRUITING
New Haven
Contact Information
Primary
Thomas Adams, PhD
thomas.adamsjr@yale.edu
(203) 974-7523
Backup
Ava Reker, B.A.
ava.reker@yale.edu
Time Frame
Start Date: 2025-09-12
Estimated Completion Date: 2029-08-01
Participants
Target number of participants: 180
Treatments
Active_comparator: Active transcranial direct current stimulation
Current will be ramped in/out for 30 seconds at the beginning and end of a 20-minute period and a constant current will be delivered for the 20-minutes between ramping.
Sham_comparator: Sham transcranial direct current stimulation
Current will be ramped in and out for 30 seconds followed by a 20-minute period during which no stimulation will be delivered.
Related Therapeutic Areas
Sponsors
Leads: Yale University
Collaborators: National Institute of Mental Health (NIMH)

This content was sourced from clinicaltrials.gov